Eckhard Wolf

Postdoctoral opening at Ludwig-Maximilians-Universität München (LMU) , in cooperation with Novartis Pharma AG and the ICON research center. The position is centered on translational pharmacokinetics , biomedical imaging , subcutaneous drug application , and the characterization of subcutaneous bolus formations and their translation into pharmacokinetic (PK) models . The project aims to translate findings from preclinical minipig models to humans, with a strong focus on understanding tissue structure, injection dynamics, drug distribution, and systemic exposure after subcutaneous administration. The research combines experimental work, imaging-based characterization, quantitative PK/modeling approaches, and comparative analysis of innovative therapeutic modalities such as antibodies, siRNA, conjugates, and highly concentrated formulations. This is an interdisciplinary academic-industrial position at the interface of university research and pharmaceutical development. The successful candidate will work closely with experts in pharmacokinetics, formulation science, translational medicine, and imaging, with access to LMU and Novartis infrastructure and technologies. Eligibility highlights: completed doctorate in a relevant field; strong interest in translational research and/or biomedical imaging; experience with preclinical animal models is advantageous; excellent English; quantitative mindset; teamwork and scientific initiative. Funding/employment: fixed-term postdoc position for 3 years with attractive working conditions. The post emphasizes strong publication opportunities, intensive supervision, and a broad academic-industrial network, but does not state a stipend amount. Application: submit a motivation letter, CV, publication list, and referee contact details electronically. Contact persons listed in the post are Dr. Karoline Bechtold-Peters, PD Dr. Sebastian Clauss, and Prof. Dr. Eckhard Wolf.